John P. Cleary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John P. Cleary has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Andrew J. Henderson
Department of Medicine and Microbiology, Boston University School of Medicine, 650 Albany St, Boston, MA, 02215, USA
1 shared publication- Busra Gok
Boston University, Boston, USA
1 shared publication - Christine S. Cheng
Department of Biology, Boston University, Boston, USA
1 shared publication - Elliot C. Nelson
Department of Psychiatry Washington University School of Medicine St. Louis Missouri USA
1 shared publication - Masanao Yajima
Department of Mathematics & Statistics, Boston University, Boston, Massachusetts
1 shared publication - Nicholas G. Martin
QIMR Berghofer Medical Research Institute
1 shared publication
Latest Publications
- Open Access
- 26 May 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Single cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program
Chronic opioid usage not only causes addiction behavior through the central nervous system, but also modulates the peripheral immune system. However, how opioid impacts the immune system is still barely characterized systematically. In order to understand the immune modulatory effect of opioids in an unbiased way, here we perform single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from opioid-dependent individuals and controls to show that chronic opioid usage evokes widespread suppression of antiviral gene program in naive monocytes, as well as in multiple immune cell types upon stimulation with the pathogen component lipopolysaccharide. Furthermore, scRNA-seq reveals the same phenomenon after a short in vitro morphine treatment. These findings indicate that both acute and chronic opioid exposure may be harmful to our immune system by suppressing the antiviral gene program. Our results suggest that further characterization of the immune modulatory effects of opioid is critical to ensure the safety of clinical opioids.
- 26 May 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Open AccessSingle cell transcriptomics reveals opioid usage evokes widespread suppression of antiviral gene program
Chronic opioid usage not only causes addiction behavior through the central nervous system, but also modulates the peripheral immune system. However, how opioid impacts the immune system is still barely characterized systematically. In order to understand the immune modulatory effect of opioids in an unbiased way, here we perform single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from opioid-dependent individuals and controls to show that chronic opioid usage evokes widespread suppression of antiviral gene program in naive monocytes, as well as in multiple immune cell types upon stimulation with the pathogen component lipopolysaccharide. Furthermore, scRNA-seq reveals the same phenomenon after a short in vitro morphine treatment. These findings indicate that both acute and chronic opioid exposure may be harmful to our immune system by suppressing the antiviral gene program. Our results suggest that further characterization of the immune modulatory effects of opioid is critical to ensure the safety of clinical opioids.